Tumor-driving IDH1 mutations affect residue R132, with R132H and R132C the most common, though more rare mutations, including R132G, R132L, R132S, and R132Q have been reported in patients (2, 11, 12, 13). The gene discussed is IDH1; the disease is neoplasm.